Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19
- PMID: 33305255
- PMCID: PMC7718446
- DOI: 10.1016/j.conx.2020.100049
Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19
Abstract
Objective: Access to abortion care in the United States (US) is restricted by numerous logistical and financial barriers, which have been further intensified by the COVID-19 pandemic. We sought to understand the ways in which COVID-19 prompted changes in clinical practices in abortion care among independent abortion clinics.
Study design: We surveyed independent US abortion clinics and documented changes in practice regarding the provision of abortion since March 1, 2020.
Results: Among about 153 independent clinics invited, 100 clinics contributed relevant data and were included in the analytic sample. A total of 87% reported changes in protocols in response to the COVID-19 pandemic. Reported changes included moving to telehealth (phone or video) for follow-up (71%), starting or increasing telehealth for patient consultations and screening (41%), reducing Rh testing (43%) and other tests (42%), and omitting the preabortion ultrasound (15%). A total of 20% reported allowing quick pickup of medication abortion pills, and 4% began mailing medications directly to patients after a telehealth consultation. Clinical practice changes were reported throughout all regions of the US, but facilities in the Northeast (73%) were more likely to report starting or increasing telehealth than facilities in the South (23%, p < .001).
Conclusion: The COVID-19 pandemic accelerated use of telehealth among independent abortion clinics, but many clinics, particularly those in the South, have been unable to make these changes. Other practices such as reducing preabortion ultrasounds were less common in all regions despite clinical guidelines and evidence supporting such changes in practice and positive benefits for public health and patient-centered care.
Implications: The COVID-19 pandemic has created a window of opportunity to remove barriers to abortion, including expanding telehealth and reducing preabortion tests. Clinics can strive for a culture shift towards simplifying the provision of medication abortion and routinely avoiding preabortion tests and in-person visits. Such changes in practice could have positive benefits for public health and patient-centered care.
Keywords: Abortion; COVID-19; Independent abortion clinics; Medication abortion; Mifepristone; Practice changes; Telehealth; USFDA REMS.
© 2020 The Authors.
Figures
Similar articles
-
Abortion service availability during the COVID-19 pandemic: Results from a national census of abortion facilities in the U.S.Contracept X. 2021;3:100067. doi: 10.1016/j.conx.2021.100067. Epub 2021 Jul 6. Contracept X. 2021. PMID: 34308330 Free PMC article.
-
Factors associated with successful implementation of telehealth abortion in 4 United States clinical practice settings.Contraception. 2021 Jul;104(1):82-91. doi: 10.1016/j.contraception.2021.04.021. Epub 2021 Apr 29. Contraception. 2021. PMID: 33932401 Free PMC article.
-
Changes to medication abortion clinical practices in response to the COVID-19 pandemic.Contraception. 2021 Jul;104(1):77-81. doi: 10.1016/j.contraception.2021.04.010. Epub 2021 Apr 21. Contraception. 2021. PMID: 33894247 Free PMC article.
-
Medication Abortion: Out of the Clinic and into the Mail.Obstet Gynecol Clin North Am. 2025 Jun;52(2):219-237. doi: 10.1016/j.ogc.2024.12.014. Epub 2025 Mar 28. Obstet Gynecol Clin North Am. 2025. PMID: 40320267 Review.
-
Visit Types in Primary Care With Telehealth Use During the COVID-19 Pandemic: Systematic Review.JMIR Med Inform. 2022 Nov 28;10(11):e40469. doi: 10.2196/40469. JMIR Med Inform. 2022. PMID: 36265039 Free PMC article. Review.
Cited by
-
The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.Fam Pract. 2021 Aug 27;38(Suppl 1):i30-i36. doi: 10.1093/fampra/cmab083. Fam Pract. 2021. PMID: 34448482 Free PMC article.
-
Pricing of medication abortion in the United States, 2021-2023.Perspect Sex Reprod Health. 2024 Sep;56(3):282-294. doi: 10.1111/psrh.12280. Epub 2024 Jul 2. Perspect Sex Reprod Health. 2024. PMID: 38956948 Free PMC article.
-
Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.Obstet Gynecol. 2022 Jun 1;139(6):1111-1122. doi: 10.1097/AOG.0000000000004757. Epub 2022 May 2. Obstet Gynecol. 2022. PMID: 35675608 Free PMC article.
-
Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US.JAMA Netw Open. 2021 May 3;4(5):e2111852. doi: 10.1001/jamanetworkopen.2021.11852. JAMA Netw Open. 2021. PMID: 34019085 Free PMC article.
-
Perspectives on Abortion Services, the Pre-Abortion Visit, and Telemedicine Abortion: A Qualitative Study in Sweden.Perspect Sex Reprod Health. 2025 Mar;57(1):36-44. doi: 10.1111/psrh.12290. Epub 2025 Jan 12. Perspect Sex Reprod Health. 2025. PMID: 39800999 Free PMC article.
References
-
- Jones R.K., Witwer E., Jerman J. Guttmacher Institute; September 2019. Abortion incidence and service availability in the United States, 2017.https://www.guttmacher.org/report/abortion-incidence-service-availabilit...
-
- Cohen D.S., Joffe C.E. University of California Press; Oakland, California: 2020. Obstacle course : the everyday struggle to get an abortion in America.
-
- Upadhyay U.D. Innovative models are needed for equitable abortion access in the USA. Lancet Public Health. 2017;2(11):E484–E485. - PubMed